Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs
The goal of this study was to explore the safety and efficacy of hyperbaric oxygen in the treatment of peripheral neuropathy due to paclitaxel analogues
Breast Cancers
DEVICE: hyperbaric oxygenation treatment|BEHAVIORAL: routine care
Difference in change in CIPN score due to paclitaxel analogues compared to baseline, Difference in change in CIPN score due to paclitaxel analogues compared to baseline, Baseline, 2 week, 4 week, 6 week, 8 week
NPS degree, Baseline, 2 week, 4 week, 6 week, 8 week|EORTC QLQ - CIPN20, Baseline, 2 week, 4 week, 6 week, 8 week|ENS score, Baseline, 2 week, 4 week, 6 week, 8 week|neuromyography, Baseline, 8 week|life quality, FACT-B Quality of Life Score, Baseline, 2 week, 4 week, 6 week, 8 week|insomnia score, Insomnia Severity Index (ISI), Baseline, 2 week, 4 week, 6 week, 8 week|depression score, Hospital Anxiety and Depression Scale (HADS), Baseline, 2 week, 4 week, 6 week, 8 week|Exhaustion score, Brief Fatigue Inventory (BFI), Baseline, 2 week, 4 week, 6 week, 8 week|Side effects of hyperbaric oxygen therapy, during the hyperbaric oxygen therapy (up to 2 months)
The goal of this study was to explore the safety and efficacy of hyperbaric oxygen in the treatment of peripheral neuropathy due to paclitaxel analogues